Will iPS cells enhance therapeutic applicability of cord blood cells and banking?
The exciting development of induced pluripotent stem cells (iPSCs), and the discovery that iPSCs can be derived from cord blood (CB), combined with the presence of nonhematopoietic stem and progenitor cells in CB may lead to enhanced therapeutic applicability of this cell source and induce increased CB banking.
Broxmeyer
Hal E
HE
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. hbroxmey@iupui.edu
D000818:Animals; D001771:Blood Banks; D002454:Cell Differentiation; D005312:Fetal Blood / Q000166:cytology*; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology*; D033581:Stem Cell Transplantation